Clinical Report: Myopia Pathways May Guide Control
Overview
This integrative review outlines the mechanisms driving myopia progression, emphasizing the interplay between environmental factors, optical signaling, and genetic susceptibility. Key findings indicate that increased outdoor exposure and specific optical interventions can significantly reduce myopia progression.
Background
Myopia is a growing global health concern, with projections suggesting that by 2050, nearly half of the world's population may be affected. Understanding the pathways that contribute to myopia development is crucial for developing effective management strategies. This review synthesizes evidence from various studies to provide insights into the biological mechanisms underlying myopia.
Data Highlights
| Intervention | Effect on Axial Elongation | Duration |
|---|---|---|
| Orthokeratology | ~33% reduction | 7 years |
| Multifocal soft contact lenses | 29% reduction | 2 years |
| Low-dose atropine (0.01%–0.05%) | 30% to 60% reduction | Varied |
Key Findings
- Near work and reduced outdoor exposure are significant contributors to myopia progression.
- One additional hour outdoors daily is linked to a 2% reduction in incident myopia.
- Orthokeratology and multifocal lenses significantly reduce axial elongation compared to single-vision correction.
- Genetic factors, including variants in the VIPR2 gene, interact with environmental exposures to influence myopia progression.
- Low-dose atropine has been shown to effectively reduce myopia progression in various studies.
Clinical Implications
Clinicians should consider a multifaceted approach to myopia management that includes increasing outdoor time and utilizing optical interventions tailored to individual patient needs. Understanding the genetic and environmental factors influencing myopia can help in personalizing treatment strategies.
Conclusion
The findings from this review support a biologically grounded, individualized approach to myopia management, emphasizing the need for tailored strategies that integrate environmental, optical, and genetic factors.
References
- Opoku-Yamoah V, et al., Eye & ENT Research, 2023 -- Myopia Pathways May Guide Control
- Contact Lens Spectrum — LIGHTING THE WAY TO MYOPIA CONTROL
- Optometric Management — Myopia Control Spectacles: Review of the Latest Research
- Contact Lens Spectrum — Myopia Beyond 2025
- Contact Lens Spectrum — Myopia Beyond 2025
- LIGHTING THE WAY TO MYOPIA CONTROL
- Myopia Control Spectacles: Review of the Latest Research
- Myopia Beyond 2025
- IMI 2025 Digest - Myopia Institute
- Five-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report - ScienceDirect
- Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
